What is arteriovenous malformation (AVM) and how is it treated at Medanta Medicity?

AVM is a rare disorder where arteries connect directly to veins without capillaries. At Medanta, it was treated using a minimally invasive technique with an EVOH liquid embolic agent.

What is the significance of the EVOH embolic agent used in the AVM procedure?

The EVOH agent allows slow, controlled delivery deep into the AVM's core, enabling occlusion in a single session, reducing complexity and recovery time compared to older methods.

Where in India was the first peripheral EVOH embolic vial used to treat AVM?

The first use of a peripheral EVOH embolic vial for AVM treatment in India occurred at Medanta Medicity in Gurugram.

Home / Health / India First: Teen AVM Treated with New Embolic Agent

India First: Teen AVM Treated with New Embolic Agent

21 Nov

•

Summary

A 16-year-old girl received a first-in-India treatment for AVM.
A minimally invasive technique used a new liquid embolic agent.
The procedure at Medanta Medicity successfully relieved severe symptoms.

India First: Teen AVM Treated with New Embolic Agent

A 16-year-old girl diagnosed with a rare congenital vascular disorder, arteriovenous malformation (AVM), has been successfully treated using a groundbreaking technique in Gurugram. This disorder, characterized by abnormal connections between arteries and veins, caused significant pain and swelling in the patient's right buttock.

The minimally invasive procedure, performed at Medanta Medicity, involved the use of ethylene-vinyl alcohol copolymer (EVOH), a liquid embolic agent typically reserved for complex neurovascular interventions. This marks the first time a peripheral EVOH embolic vial was employed in India for such a condition, offering a precise and controlled method to occlude the abnormal vessels.

The surgery, lasting two hours, effectively treated the AVM and relieved the young patient from symptoms including severe pain, swelling, skin changes, and fever. Doctors highlighted the success as a significant advancement in image-guided interventions for managing high-flow AVMs, especially in young patients where early recognition and treatment are crucial to prevent tissue damage and potentially life-threatening complications.